Orange Grove Bio

Orange Grove Bio ("OGB") is a preclinical drug investment and development platform focused on reducing the cost of drug discovery and advancing therapies into clinical trials. Orange Grove also acquires projects by investing in biotechnology companies at the preclinical stage. Orange Grove Bio's experienced development team collaborates with these companies to more efficiently advance projects into clinical stages and reach additional value inflection points.We have a particular interest in treatments for oncology, inflammatory, and autoimmune diseases and are committed to all different therapeutic modalities.